22.11
1.73%
-0.39
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
16.75%
70.50
|
84.69 | 67.85 | 66.17 | 67.70 |
Cost Of Revenue |
0.97%
45.28
|
44.84 | 47.28 | 47.36 | 54.72 |
Gross Profit |
36.68%
25.23
|
39.84 | 20.57 | 18.81 | 12.99 |
Operating Expenses
|
344.99%
176.35
|
39.63 | 40.37 | 43.63 | 49.54 |
Benefits Costs and Expenses |
177.15%
215.70
|
77.83 | 82.55 | 87.22 | 101.17 |
Costs And Expenses |
177.15%
215.70
|
77.83 | 82.55 | 87.22 | 101.17 |
Operating Income/Loss |
70,717%
-151.12
|
0.214 | -19.80 | -24.82 | -36.55 |
Income/Loss From Continuing Operations Before Tax |
2,217%
-145.20
|
6.86 | -14.70 | -21.05 | -33.46 |
Income Tax Expense/Benefit, Deferred |
97.41%
0.502
|
19.38 | -3.218 | -5.20 | -3.346 |
Income Tax Expense/Benefit |
153.44%
-10.86
|
20.33 | -3.11 | -5.20 | -9.386 |
Income/Loss From Continuing Operations After Tax |
897.58%
-134.33
|
-13.47 | -11.59 | -15.85 | -24.08 |
Net Income/Loss
|
897.58%
-134.33
|
-13.47 | -11.59 | -15.85 | -24.08 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
1,623%
-6.185
|
-0.359 | -0.361 | -0.509 | -0.244 |
Basic Average Shares |
100.02%
-0.005
|
30.01 | 29.81 | 29.54 | -0.159 |
Diluted Average Shares |
100.02%
-0.005
|
30.01 | 29.81 | 29.54 | -0.143 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):